Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Associations of insulin resistance and adiponectin with mortality in women with breast cancer.

Duggan C, Irwin ML, Xiao L, Henderson KD, Smith AW, Baumgartner RN, Baumgartner KB, Bernstein L, Ballard-Barbash R, McTiernan A.

J Clin Oncol. 2011 Jan 1;29(1):32-9. doi: 10.1200/JCO.2009.26.4473. Epub 2010 Nov 29.

2.

Central adiposity after breast cancer diagnosis is related to mortality in the Health, Eating, Activity, and Lifestyle study.

George SM, Bernstein L, Smith AW, Neuhouser ML, Baumgartner KB, Baumgartner RN, Ballard-Barbash R.

Breast Cancer Res Treat. 2014 Aug;146(3):647-55. doi: 10.1007/s10549-014-3048-x. Epub 2014 Jul 24.

PMID:
25056184
3.

Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.

Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL, Kaplan RC, Harris TG, Howard BV, Wylie-Rosett J, Burk RD, Strickler HD.

J Natl Cancer Inst. 2009 Jan 7;101(1):48-60. doi: 10.1093/jnci/djn415. Epub 2008 Dec 30.

4.

Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer.

Duggan C, Wang CY, Neuhouser ML, Xiao L, Smith AW, Reding KW, Baumgartner RN, Baumgartner KB, Bernstein L, Ballard-Barbash R, McTiernan A.

Int J Cancer. 2013 Mar 1;132(5):1191-200. doi: 10.1002/ijc.27753. Epub 2012 Sep 1.

5.

Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.

Duggan C, Onstad L, Hardikar S, Blount PL, Reid BJ, Vaughan TL.

Clin Gastroenterol Hepatol. 2013 Aug;11(8):934-43. doi: 10.1016/j.cgh.2013.02.017. Epub 2013 Mar 1.

6.

Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project.

Kwan ML, Chen WY, Kroenke CH, Weltzien EK, Beasley JM, Nechuta SJ, Poole EM, Lu W, Holmes MD, Quesenberry CP Jr, Pierce JP, Shu XO, Caan BJ.

Breast Cancer Res Treat. 2012 Apr;132(2):729-39. doi: 10.1007/s10549-011-1914-3. Epub 2011 Dec 21.

7.

Change in peripheral blood leukocyte telomere length and mortality in breast cancer survivors.

Duggan C, Risques R, Alfano C, Prunkard D, Imayama I, Holte S, Baumgartner K, Baumgartner R, Bernstein L, Ballard-Barbash R, Rabinovitch P, McTiernan A.

J Natl Cancer Inst. 2014 Apr;106(4):dju035. doi: 10.1093/jnci/dju035. Epub 2014 Mar 13.

8.

Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience.

Capasso I, Esposito E, Pentimalli F, Montella M, Crispo A, Maurea N, D'Aiuto M, Fucito A, Grimaldi M, Cavalcanti E, Esposito G, Brillante G, Lodato S, Pedicini T, D'Aiuto G, Ciliberto G, Giordano A.

J Exp Clin Cancer Res. 2013 Mar 14;32:14. doi: 10.1186/1756-9966-32-14.

9.

Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.

Singh S, Akhtar N, Ahmad J.

Diabetes Metab Syndr. 2012 Oct-Dec;6(4):207-11. doi: 10.1016/j.dsx.2012.05.013. Epub 2012 Jul 6.

PMID:
23199540
10.

Relationship of serum isoflavone, insulin and adiponectin levels with breast cancer risk.

Minatoya M, Kutomi G, Asakura S, Otokozawa S, Sugiyama Y, Ohnishi H, Akasaka H, Miura T, Mori M, Hirata K.

Breast Cancer. 2015 Sep;22(5):452-61. doi: 10.1007/s12282-013-0502-2. Epub 2013 Oct 29.

PMID:
24166746
11.

Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study.

Irwin ML, Duggan C, Wang CY, Smith AW, McTiernan A, Baumgartner RN, Baumgartner KB, Bernstein L, Ballard-Barbash R.

J Clin Oncol. 2011 Jan 1;29(1):47-53. doi: 10.1200/JCO.2010.28.4752. Epub 2010 Nov 29.

12.

Association of the + 45T>G adiponectin gene polymorphism with insulin resistance in non-diabetic Saudi women.

Mackawy AM.

Gene. 2013 Nov 1;530(1):158-63. doi: 10.1016/j.gene.2013.07.003. Epub 2013 Aug 17.

PMID:
23958652
13.

Catecholamines, adiponectin, and insulin resistance as measured by HOMA in children with obstructive sleep apnea.

Kelly A, Dougherty S, Cucchiara A, Marcus CL, Brooks LJ.

Sleep. 2010 Sep;33(9):1185-91.

14.

The presentation of metabolic dysfunction and the relationship with energy output in breast cancer survivors: a cross-sectional study.

Guinan EM, Connolly EM, Kennedy MJ, Hussey J.

Nutr J. 2013 Jul 15;12:99. doi: 10.1186/1475-2891-12-99.

15.

Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study.

van Himbergen TM, Beiser AS, Ai M, Seshadri S, Otokozawa S, Au R, Thongtang N, Wolf PA, Schaefer EJ.

Arch Neurol. 2012 May;69(5):594-600.

16.

Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study.

Conroy SM, Maskarinec G, Wilkens LR, White KK, Henderson BE, Kolonel LN.

Breast Cancer Res Treat. 2011 Sep;129(2):565-74. doi: 10.1007/s10549-011-1468-4. Epub 2011 Apr 16.

17.

Adiponectin and insulin resistance in childhood obesity.

Panagopoulou P, Galli-Tsinopoulou A, Fleva A, Pavlitou-Tsiontsi E, Vavatsi-Christaki N, Nousia-Arvanitakis S.

J Pediatr Gastroenterol Nutr. 2008 Sep;47(3):356-62. doi: 10.1097/MPG.0b013e31817fcb67.

PMID:
18728534
18.

Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.

Macis D, Gandini S, Guerrieri-Gonzaga A, Johansson H, Magni P, Ruscica M, Lazzeroni M, Serrano D, Cazzaniga M, Mora S, Feroce I, Pizzamiglio M, Sandri MT, Gulisano M, Bonanni B, Decensi A.

J Clin Oncol. 2012 Jan 10;30(2):151-7. doi: 10.1200/JCO.2011.35.2237. Epub 2011 Dec 12.

19.

Plasma adiponectin and insulin sensitivity in overweight and normal-weight middle-aged premenopausal women.

Jürimäe J, Jürimäe T, Ring-Dimitriou S, LeMura LM, Arciero PJ, von Duvillard SP.

Metabolism. 2009 May;58(5):638-43. doi: 10.1016/j.metabol.2008.12.009.

PMID:
19375586
20.

Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.

Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP.

J Natl Cancer Inst. 2003 Oct 1;95(19):1467-76.

Supplemental Content

Support Center